Switch to:
CytRx Corp (NAS:CYTR)
EV/EBITDA
0.08 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, CytRx Corp's enterprise value is $-4.65 Mil. CytRx Corp's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2016 was $-59.27 Mil. Therefore, CytRx Corp's EV/EBITDA ratio for today is 0.08.

CYTR' s EV/EBITDA Range Over the Past 10 Years
Min: -17.7   Max: 0.2
Current: 0.07

-17.7
0.2

During the past 13 years, the highest EV/EBITDA Ratio of CytRx Corp was 0.20. The lowest was -17.70. And the median was -2.70.

CYTR's EV/EBITDA is ranked higher than
99% of the 304 Companies
in the Global Biotechnology industry.

( Industry Median: 18.12 vs. CYTR: 0.07 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, CytRx Corp's stock price is $0.60. CytRx Corp's earnings per share for the trailing twelve months (TTM) ended in Mar. 2016 was $-0.85. Therefore, CytRx Corp's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

CytRx Corp's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=-4.646/-59.274
=0.08

CytRx Corp's current Enterprise Value is $-4.65 Mil.
CytRx Corp's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2016 was -14.123 (Jun. 2015 ) + -10.585 (Sep. 2015 ) + -22.442 (Dec. 2015 ) + -12.124 (Mar. 2016 ) = $-59.27 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

CytRx Corp's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=0.60/-0.845
=

CytRx Corp's share price for today is $0.60.
CytRx Corp's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2016 was -0.21 (Jun. 2015 ) + -0.11 (Sep. 2015 ) + -0.335 (Dec. 2015 ) + -0.19 (Mar. 2016 ) = $-0.85.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

CytRx Corp Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda -5.96-7.53-0.13-12.55-5.05-0.25-0.90-8.21-1.53-1.84

CytRx Corp Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
ev2ebitda -8.21-2.49-3.32-1.12-1.53-2.16-2.68-1.57-1.84-2.25
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK